Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Consistency and Immunogenicity of GSK's Hib Conjugate Vaccine (Hiberix) in Healthy Infants
NCT01000974Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Primary completion
- Nov 2011
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Haemophilus b conjugate vaccine in Haemophilus influenzae type b infection (Hib), sponsored by GSK. Started Jun 2010; status: completed.
02
Drugs
Haemophilus b conjugate vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01000974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01000974.